More about

Sacituzumab Govitecan

News
October 18, 2024
1 min read
Save

Gilead to withdraw Trodelvy accelerated approval for bladder cancer

Gilead to withdraw Trodelvy accelerated approval for bladder cancer

Gilead Sciences announced its intention to voluntarily withdraw the accelerated approval for sacituzumab govitecan-hziv for treatment of certain patients with advanced bladder cancer.

News
October 05, 2024
1 min read
Save

Breast Cancer Awareness Month: New insights into lymphedema, genetic testing and AI

Breast Cancer Awareness Month: New insights into lymphedema, genetic testing and AI

Breast Cancer Awareness Month is observed every October.

News
August 30, 2024
3 min read
Save

Drug shows ‘very promising’ activity in breast cancer brain metastases

Drug shows ‘very promising’ activity in breast cancer brain metastases

Sacituzumab govitecan-hziy exhibited efficacy as therapy for two traditionally difficult-to-treat populations, according to results of a window-of-opportunity trial.

News
May 02, 2024
2 min watch
Save

VIDEO: Precision medicine ‘evolving’ in metastatic breast cancer

VIDEO: Precision medicine ‘evolving’ in metastatic breast cancer

Healio spoke with Paolo Tarantino, MD, about FDA approvals in metastatic breast cancer.

News
April 11, 2024
4 min watch
Save

VIDEO: Important areas of future research for triple-negative breast cancer

VIDEO: Important areas of future research for triple-negative breast cancer

Healio spoke with Wendy Chen, MD, MPH about recent advancements in metastatic triple-negative breast cancer.

News
April 11, 2024
3 min watch
Save

VIDEO: Challenges of treating metastatic triple-negative breast cancer vs. other breast cancers

VIDEO: Challenges of treating metastatic triple-negative breast cancer vs. other breast cancers

Healio spoke with Wendy Chen, MD, MPH about recent advancements in metastatic triple-negative breast cancer.

News
April 11, 2024
5 min watch
Save

VIDEO: Optimizing treatment approach after chemotherapy in triple-negative breast cancer

VIDEO: Optimizing treatment approach after chemotherapy in triple-negative breast cancer

Healio spoke with Wendy Chen, MD, MPH about recent advancements in metastatic triple-negative breast cancer.

News
April 11, 2024
2 min watch
Save

VIDEO: Navigating the conversation after diagnosis of metastatic triple-negative breast cancer

VIDEO: Navigating the conversation after diagnosis of metastatic triple-negative breast cancer

Healio spoke with Wendy Chen, MD, MPH about recent advancements in metastatic triple-negative breast cancer.

News
April 11, 2024
2 min watch
Save

VIDEO: Combination therapies showing promise in metastatic triple-negative breast cancer

VIDEO: Combination therapies showing promise in metastatic triple-negative breast cancer

Healio spoke with Wendy Chen, MD, MPH about recent advancements in metastatic triple-negative breast cancer.

News
January 23, 2024
1 min read
Save

Phase 3 study of Trodelvy for advanced lung cancer misses primary endpoint

Phase 3 study of Trodelvy for advanced lung cancer misses primary endpoint

A randomized phase 3 study designed to assess sacituzumab govitecan-hziy for treatment of previously treated metastatic non-small cell lung cancer failed to meet its primary endpoint of OS, according to the agent’s manufacturer.

View more